Fluctuating blood sugar levels are more than just an energy rollercoaster—they could offer crucial clues for diabetes detection risk early. Researchers at the University of Tokyo have unveiled a groundbreaking, noninvasive method to assess blood glucose regulation, potentially reducing the need for painful needle pricks and complex procedures.
A Simpler Way to Spot the Risk
The research team focused on continuous glucose monitoring (CGM), a wearable technology that tracks glucose levels in real-time. By analyzing this data, they developed a new way to assess how the body handles glucose—an essential marker for predicting diabetes. This innovative approach promises to make early detection easier and more accessible.
As reported by Medical Xpress, the findings have been published in the journal Communications Medicine, highlighting the potential for a major shift in diabetes screening strategies.
The Silent Threat of Diabetes
Often dubbed a “silent epidemic,” diabetes continues to rise globally, placing a massive burden on both public health and economies. Early detection of impaired glucose regulation—a condition that lies between normal levels and full-blown diabetes—can play a crucial role in delaying or even preventing type 2 diabetes.
However, current diagnostic methods fall short. Traditional tests rely on single-time blood samples and often fail to catch early metabolic changes. “Traditional diabetes tests, while useful, do not capture the dynamic nature of glucose regulation under physiological conditions,” explained Professor Shinya Kuroda, co-author of the study.
Real-Life Glucose Insights with CGM
To explore a more practical solution, the team studied 64 participants who had no previous diabetes diagnosis. They equipped each subject with a CGM device and conducted standard diagnostic tests, including the oral glucose tolerance test (OGTT) and insulin clamp tests. Using this data, they developed and validated a model through both an independent dataset and mathematical simulations.
Their key metric, AC_Var—a measure of glucose fluctuations—showed a strong correlation with the disposition index, a reliable predictor of future diabetes. When paired with glucose standard deviation, the model outperformed conventional indicators like fasting glucose, HbA1c, and OGTT results.
Detecting the Invisible
With this new CGM-based algorithm, the researchers identified impaired glucose control even in individuals who appeared healthy under traditional tests. “This means we can potentially detect issues much earlier, creating an opportunity for preventive interventions before diabetes is diagnosed,” said Kuroda.
Notably, the new method also proved more accurate at predicting diabetes-related complications such as coronary artery disease. This added layer of precision makes it a powerful tool not just for screening but also for anticipating future health risks.
Making the Technology Accessible
To bring this approach to a wider audience, the team created a user-friendly web application that allows both individuals and healthcare professionals to calculate CGM-based indices easily.